Journals / Retina-Vitreus / 2018 / Cilt: 27 - Sayı: 2

Intravitreal Afl ibercept Treatment For Extrafoveal Choroidal Neovascularization Secondary To Angioid Streaks Related To Pseudoxanthoma Elasticum

Psödoksantoma Elastikum ile İlişkili Anjioid Streakse Sekonder Ekstrafoveal Koroid Neovaskülarizasyonunda İntravitreal Afl ibersept Tedavisi

Pages
174–177
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intravitreal afl ibersept injection is a successful treatment option that can be prefered in such cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Choroidal neovascularization (CNV) is seen in 42-86 % of the patients with angioid streaks (AS) that is characterized by the fragility and cracking of the Bruch’s membrane and can cause signifi cant visual loss if not treated.
📊
Key Findings & Data:Rapid regression was achieved in the CNV and no recurrence was seen at 6 months follow-up.
💡
Conclusion & Impact:Intravitreal afl ibersept injection is a successful treatment option that can be prefered in such cases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Choroidal neovascularization (CNV) is seen in 42-86 % of the patients with angioid streaks (AS) that is characterized by the fragility and cracking of the Bruch’s membrane and can cause signifi cant visual loss if not treated. In addition, recurrence is frequent in the cases with AS associated CNV (AS-CNV). In this paper, a case of single dose intravitreal afl ibersept injection for extrafoveal AS-CNV related to pseudoxanthoma elasticum is presented. Rapid regression was achieved in the CNV and no recurrence was seen at 6 months follow-up. Intravitreal afl ibersept injection is a successful treatment option that can be prefered in such cases.

Özet

Bruch membranının kırılgan olması ve çatlaması ile karakterize olan anjioid streaks (AS)’te koroid neovaskülarizasyonu (KNV) % 42-86 oranında görülür ve tedavi edilmezse önemli görme kaybına neden olabilir. Ayrıca AS zemininde gelişen KNV’de nüks sık görülmektedir. Bu yazıda psödoksantoma elastikum ile ilişkili AS’ye sekonder ekstrafoveal KNV için tek doz intravitreal afl ibersept enjeksiyonu yapılmış bir olgu sunulmaktadır. KNV’de hızlı gerileme elde edilmiş ve 6 aylık takipte nüks görülmemiştir. İntravitreal afl ibersept enjeksiyonu bu tür olgularda tercih edilebilecek başarılı bir tedavi yöntemidir.

🔖

Cite This Article

KARAMAN, S. K., KELEŞ, A. (2018). Intravitreal Afl ibercept Treatment For Extrafoveal Choroidal Neovascularization Secondary To Angioid Streaks Related To Pseudoxanthoma Elasticum. Retina-Vitreus, Cilt: 27 - Sayı: 2, 174–177. https://ajindex.com/articles/304853

References (12)

  1. Gliem M, Figuer RP, Fimmers R, et al. Treatment of choroıdal streaks. A comprehensive review. Retina. 2013;33:1300-14.
  2. Al-Rashaed S, Arevalo JF. Long-term follow-up of choroidal neovascularization secondary to angioid streaks: case series and literature review. Clin Ophthalmol. 2012;6:1029-34.
  3. Martinez-Serrano MG, Rodriguez-Reyes A, Guerrero-Naranjo JL, et al. Long-term follow-up of patients with choroidal neovascularization due to angioid streaks. Clin Ophthalmol. 2016;11:23-30. Clarkson JG AR. Angioid streaks. Surv Ophthalmol. 1982;26:235- 46. Finger RP, Charbel Issa P, Ladewig MS, et al. Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol. 2009;54:272-85.
  4. Finger RP, Charbel Issa P, Schmitz-Valckenberg S, et al. Long- term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Retina. 2011;31:1268-78.
  5. Pece A, Avanza P, Galli L, et al. Laser photocoagulation of choroidal neovascularization in angioid streaks. Retina. 1997;17:12-6.
  6. Menchini U, Virgili G, Introini U, et al. Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina. 2004;24:763-71.
  7. Gupta B, Elagouz M, Sivaprasad S. Intravitreal bevacizumab for choroidal neovascularisation secondary to causes other than age- related macular degeneration. Eye (Lond). 2010;24:203-13.
  8. Alagöz C, Alagöz N, Özkaya A, et al. Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membrane Due To Angioid Streaks. Retina. 2015;35:2001-10.
  9. Tilleul J, Mimoun G, Querques G, et al. Intravıtreal Ranıbızumab For Choroıdal Neovascularızatıon In Four-Year Follow-Up. Retina. 2016;36:483-91.
  10. Vaz-Pereira S, Collaço L, De Salvo G, et al. Intravitreal afl ibercept for choroidal neovascularisation in angioid streaks. Eye (Lond). 2015;29:1236-8.
  11. Esen E, Sizmaz S, Demircan N. Intravitreal afl ibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks. Indian J Ophthalmol. 2015;63:616-8.
  12. Tetikoglu M, Sagdik HM, Aktas S, et al. Intravitreal afl ibercept for refractory choroidal neovascularization secondary to angioid streaks. Eye (Lond). 2016;30:894-5.